125 related articles for article (PubMed ID: 36167627)
1. Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS).
Badachhape AA; Bhandari P; Devkota L; Srivastava M; Tanifum EA; George V; Fox KA; Yallampalli C; Annapragada AV; Ghaghada KB
Acad Radiol; 2023 Jul; 30(7):1384-1391. PubMed ID: 36167627
[TBL] [Abstract][Full Text] [Related]
2. Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS).
Badachhape AA; Burnett B; Bhandari P; Devkota L; Bhavane R; Ghaghada KB; Yallampalli C; Fox KA; Annapragada AV
medRxiv; 2023 Mar; ():. PubMed ID: 36993653
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation.
Badachhape AA; Kumar A; Ghaghada KB; Stupin IV; Srivastava M; Devkota L; Starosolski Z; Tanifum EA; George V; Fox KA; Yallampalli C; Annapragada AV
Placenta; 2019 Feb; 77():1-7. PubMed ID: 30827350
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta.
Ghaghada KB; Starosolski ZA; Bhayana S; Stupin I; Patel CV; Bhavane RC; Gao H; Bednov A; Yallampalli C; Belfort M; George V; Annapragada AV
Placenta; 2017 Sep; 57():60-70. PubMed ID: 28864020
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model.
Badachhape AA; Devkota L; Stupin IV; Sarkar P; Srivastava M; Tanifum EA; Fox KA; Yallampalli C; Annapragada AV; Ghaghada KB
Sci Rep; 2019 Dec; 9(1):18707. PubMed ID: 31822711
[TBL] [Abstract][Full Text] [Related]
6. A liposomal Gd contrast agent does not cross the mouse placental barrier.
Shetty AN; Pautler R; Ghaghada K; Rendon D; Gao H; Starosolski Z; Bhavane R; Patel C; Annapragada A; Yallampalli C; Lee W
Sci Rep; 2016 Jun; 6():27863. PubMed ID: 27298076
[TBL] [Abstract][Full Text] [Related]
7. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
[TBL] [Abstract][Full Text] [Related]
8. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
[TBL] [Abstract][Full Text] [Related]
9. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
[No Abstract] [Full Text] [Related]
10. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
[TBL] [Abstract][Full Text] [Related]
11. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
[TBL] [Abstract][Full Text] [Related]
12. Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors.
Badea CT; Clark DP; Holbrook M; Srivastava M; Mowery Y; Ghaghada KB
Phys Med Biol; 2019 Mar; 64(6):065007. PubMed ID: 30708357
[TBL] [Abstract][Full Text] [Related]
13. [Accuracy of placenta accreta prenatal diagnosis by ultrasound and MRI in a high-risk population].
Daney de Marcillac F; Molière S; Pinton A; Weingertner AS; Fritz G; Viville B; Roedlich MN; Gaudineau A; Sananes N; Favre R; Nisand I; Langer B
J Gynecol Obstet Biol Reprod (Paris); 2016 Feb; 45(2):198-206. PubMed ID: 26321608
[TBL] [Abstract][Full Text] [Related]
14. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders.
Jha P; Pōder L; Bourgioti C; Bharwani N; Lewis S; Kamath A; Nougaret S; Soyer P; Weston M; Castillo RP; Kido A; Forstner R; Masselli G
Eur Radiol; 2020 May; 30(5):2604-2615. PubMed ID: 32040730
[TBL] [Abstract][Full Text] [Related]
15. Comparison between a prenatal sonographic scoring system and a clinical grading at delivery for Placenta Accreta Spectrum disorders.
Pekar-Zlotin M; Maymon R; Eliassi Revivo P; Ezratty J; Melcer Y; Kugler N; Jauniaux E
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8810-8816. PubMed ID: 34818979
[TBL] [Abstract][Full Text] [Related]
16. Ferumoxytol-enhanced MR demonstration of changes to internal placental structure in placenta accreta spectrum: Preliminary findings.
Kliewer MA; Bockoven CG; Reeder SB; Bagley AR; Sadowski EA; Iruretagoyena JI; Beninati MJ; Fritsch MK
Placenta; 2023 Mar; 134():1-8. PubMed ID: 36807998
[TBL] [Abstract][Full Text] [Related]
17. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast enhanced MRI of the placenta: A tool for prenatal diagnosis of placenta accreta?
Millischer AE; Deloison B; Silvera S; Ville Y; Boddaert N; Balvay D; Siauve N; Cuenod CA; Tsatsaris V; Sentilhes L; Salomon LJ
Placenta; 2017 May; 53():40-47. PubMed ID: 28487019
[TBL] [Abstract][Full Text] [Related]
19. Functional imaging of the human placenta with magnetic resonance.
Siauve N; Chalouhi GE; Deloison B; Alison M; Clement O; Ville Y; Salomon LJ
Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S103-14. PubMed ID: 26428488
[TBL] [Abstract][Full Text] [Related]
20. Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta.
Budorick NE; Figueroa R; Vizcarra M; Shin J
J Matern Fetal Neonatal Med; 2017 Oct; 30(20):2422-2427. PubMed ID: 27806657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
